2023 Fibronectin, Integrins and Related Molecules Gordon Research Conference and Gordon Research Seminar
2023 Fibronectin, Integrins and Related Molecules Gordon Research Conference and Gordon Research Seminar
批准号:
10608783
负责人:
AMBRA POZZI
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-12-15 至 2023-11-30
关键词:
AdhesionsAreaBehaviorBiochemicalBiophysicsCOVID-19CaliforniaCell AdhesionCell Differentiation processCell physiologyCellsCollaborationsCommunicationCuesDataDevelopmentDiseaseDisease ProgressionECM receptorEnsureExtracellular MatrixFibronectinsFibrosisFosteringGoalsHealthHomeostasisHumanImageIndustryIntegrinsInternationalInvadedKnowledgeLifeMalignant NeoplasmsMentorsMicroscopyModelingModificationMolecularNormal tissue morphologyOralParticipantPersonsPhysiologyPlayPostdoctoral FellowProcessRecyclingResearchResearch PersonnelRoleScheduleScientistSeminalSignal TransductionStructureStudentsTherapeuticTherapeutic InterventionThinkingTissuesTrainingTraining and EducationTranslatingTravelUnderrepresented PopulationsUpdateVisualizationWorkbiophysical propertiescareercell behaviorcell motilitydiversity and inclusiongraduate studenthuman diseaseimprovedinsightlecturesmechanical propertiesmechanotransductionmeetingsmembermigrationnext generationnovelnovel therapeutic interventionnovel therapeuticsposterspreventprogramsreceptorsuccesssymposiumtargeted treatmenttherapeutic developmenttooltool developmenttrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
We request partial support for the “Fibronectin, Integrin, and Related Molecules” Gordon Research Conference
(GRC) and Gordon Research Seminar (GRS), February 4-10, 2023 at the Marriot Hotel, Ventura, California. This
GRC was scheduled for February 2021, but due to COVID-19-imposed travel restrictions for both US and non-
US participants, a decision was made to postpone it to 2023. The primary goal of this `in person only' GRC is
to increase understanding of how biochemical and biophysical cues from the extracellular matrix (ECM) control
cell-ECM signaling, thus regulating cellular and tissue homeostasis. We will also focus on how perturbations in
this dialogue promote diseases in which the ECM is now known to play a key role, such as fibrosis and cancer.
The latest research that delineates the way cell-ECM adhesion is controlled will be explored in-depth. We will
address how receptor-ECM interaction is sensed and interpreted by cells; how cell-ECM adhesion can be
visualized particularly in living cells; and how cell-ECM communication becomes perturbed in diseases and how
this may be targeted therapeutically. The second goal is to contribute to training the next generation of
scientists, and to foster the careers of junior investigators in this research area. The GRS preceding the GRC
will also maximize the opportunity for trainees to present and discuss their research, and to obtain mentoring
and networking opportunities from established scientists. Both meetings will bring together diverse cell-ECM
researchers and outside experts to share their latest work, thereby stimulating new ideas and solving important
problems in this research area. They will generate new collaborations, thereby sustaining and expanding the
field, and provide new opportunities to develop novel therapeutic strategies. The GRC/GRS will nucleate around
32 invited speakers that include young/mid-term investigators who are performing the cutting edge of research
in the conference topic. In addition to the established invited speakers, each of the sessions will feature talks
from graduate students, post-docs and early career investigators. They will be selected from submitted abstracts
to create opportunities for discussion of late-breaking discoveries and incorporate exciting research as oral
presentations. Moreover, two or three of the best speakers from the GRS will be selected for a short talk at the
GRC. The GRS will include two invited lectures by leaders in the field and 12 talks selected from up to 50 of the
participants. Both programs will hold poster sessions to maximize scientific discussion, some of which will be
selected for talks. New topics for this conference include mechanosensing and mechanobiology; how integrin
structures can lead to the development of therapeutic tools; state-of-the-art microscopy to study integrin recycling
and signaling; and cell-ECM interactions in fibrotic diseases and cancer migration/invasion. Updates on topics
such as tension-sensing and signaling, mechanisms of cell migration, and models of adhesion signaling in health
and disease are also included. Overall, this international conference will showcase the major advances in the
field of cell-ECM interactions research and will be, as it has always been, the seminal conference in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ASMB 2023: Tissue, Matrix, and Pathobiology
-
批准号:10752769
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2023
-
负责人:AMBRA POZZI
-
依托单位:
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10618237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AMBRA POZZI
-
依托单位:
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10451496
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:8840580
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Molecular Mechanisms of Kidney Fibrosis
-
批准号:10480325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:8649036
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8803358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8442087
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8971990
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8666537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:8500566
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:10047698
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:9321730
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:9248704
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:8677805
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:8520263
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:8371968
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS
-
批准号:7568445
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2008
-
负责人:AMBRA POZZI
-
依托单位:
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy
-
批准号:7262465
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2005
-
负责人:AMBRA POZZI
-
依托单位:
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy
-
批准号:7471435
-
项目类别:
-
资助金额:$24.96万
-
财政年份:2005
-
负责人:AMBRA POZZI
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: